Safety and Preliminary Clinical Activity of Itolizumab in Dermatomyositis
Condition(s):Dermatomyositis, Adult TypeLast Updated:August 14, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Dermatomyositis, Adult TypeLast Updated:August 14, 2023Not yet recruiting
Condition(s):DermatomyositisLast Updated:March 7, 2024Not yet recruiting
Condition(s):Lupus Erythematosus, SystemicLast Updated:March 7, 2024Recruiting
Condition(s):Lupus Erythematosus, SystemicLast Updated:March 7, 2024Recruiting
Condition(s):Juvenile DermatomyositisLast Updated:August 19, 2022Completed
Condition(s):Gastric Mucosal Manifestations in Patients With DermatomyositisLast Updated:June 2, 2022Recruiting
Condition(s):DermatomyositisLast Updated:October 30, 2023Active, not recruiting
Condition(s):DermatomyositisLast Updated:March 25, 2024Recruiting
Condition(s):Dermatomyositis, Adult TypeLast Updated:July 19, 2021Unknown status
Condition(s):Dermatomyositis; Respiratory InjuryLast Updated:July 1, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.